B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA).

Saved in:
Bibliographic Details
Title: B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA).
Authors: Infante MS; Hematology Deparment, Hospital Universitario Infanta Leonor, Madrid, Spain>., Salmanton-García J; Faculty of Medicine and University Hospital Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), University of Cologne, Cologne, Germany., Fernández-Cruz A; Hospital Universitario Puerta de Hierro, Majadahonda, Spain., Marchesi F; Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Jaksic O; Department of Hematology, University Hospital Dubrava, Zagreb, Croatia., Weinbergerová B; Department of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czechia., Besson C; Centre Hospitalier de Versailles, Versailles, France., Duarte RF; Hospital Universitario Puerta de Hierro, Majadahonda, Spain., Itri F; San Luigi Gonzaga Hospital - Orbassano, Orbassano, Italy., Valković T; University Hospital Centre Rijeka, Rijeka, Croatia.; Croatian Cooperative Group for Hematological Diseases (CROHEM), Zagreb, Croatia.; Faculty of Medicine and Faculty of Health Studies University of Rijeka, Rijeka, Croatia., Szotkovski T; University Hospital Olomouc, Olomouc, Czechia., Busca A; Stem Cell Transplant Center, AOU Citta' della Salute e della Scienza, Turin, Italy., Guidetti A; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Glenthøj A; Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Collins GP; NIHR Oxford Biomedical Research Centre, Churchill Hospital, Oxford, United Kingdom., Bonuomo V; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy., Sili U; Department of Infectious Diseases and Clinical Microbiology, School of Medicine, Marmara University, Istanbul, Turkey., Seval GC; Ankara University, Ankara, Turkey., Machado M; Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Cordoba R; Health Research Institute IIS-FJD, Fundación Jimenez Diaz University Hospital, Madrid, Spain., Blennow O; Department of Infectious Diseases and Clinical Microbiology, School of Medicine, Marmara University, Istanbul, Turkey., Abu-Zeinah G; Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY, United States., Lamure S; Departement d'Hematologie Clinique, CHU de Montpellier, UMR-CNRS 5535, Universite de Montpellier, Montpellier, France., Kulasekararaj A; King's College Hospital, London, United Kingdom.; King's College London, London, United Kingdom., Falces-Romero I; La Paz University Hospital, Madrid, Spain., Cattaneo C; Hematology Unit, ASST-Spedali Civili, Brescia, Italy., Van Doesum J; University Medical Center Groningen, Groningen, Netherlands., Piukovics K; Department of Internal Medicine, Albert Szent-Györgyi Health Center, Faculty of Medicine University of Szeged, Szeged, Hungary., Omrani AS; Communicable Disease Center, Hamad Medical Corporation, Doha, Qatar., Magliano G; ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Ledoux MP; ICANS, Strasbourg, France., de Ramon C; Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain.; IBSAL, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain., Cabirta A; Department of Hematology, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona, Spain.; Hospital Campus, Barcelona, Spain.; Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain., Verga L; Azienda Ospedaliera San Gerardo - Monza, Monza, Italy.; Università Milano-Bicocca, Milan, Italy., López-García A; Health Research Institute IIS-FJD, Fundacion Jimenez Diaz University Hospital, Madrid, Spain., Da Silva MG; Portuguese Institute of Oncology, Lisbon, Portugal., Stojanoski Z; University Clinic of Hematology, Skopje, North Macedonia., Meers S; AZ KLINA, Brasschaat, Belgium., Lahmer T; Medizinische Klinik II, Klinikum rechts der Isar, TU München, Munich, Germany., Martín-Pérez S; Hospital Nuestra Señora de Sonsoles, Ávila, Spain., Dávila-Vals J; Hospital Nuestra Señora de Sonsoles, Ávila, Spain., Van Praet J; Department of Nephrology and Infectious Diseases, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium., Samarkos M; Laikon General Hospital, Athens, Greece., Bilgin YM; ADRZ, Goes, Netherlands., Karlsson LK; Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Batinić J; UHC Zagreb, Zagreb, Croatia., Nordlander A; Department of Infectious Diseases and Clinical Microbiology, School of Medicine, Marmara University, Istanbul, Turkey., Schönlein M; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Hoenigl M; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, San Diego, CA, United States.; Clinical and Translational Fungal-Working Group, University of California San Diego, La Jolla, CA, United States.; Division of Infectious Diseases, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Ráčil Z; Institute of Hematology and Blood Transfusion, Prague, Czechia., Mladenović M; COVID Hospital 'Batajnica', Belgrade, Serbia., Hanakova M; Institute of Hematology and Blood Transfusion, Prague, Czechia., Zambrotta GPM; Azienda Ospedaliera San Gerardo - Monza, Monza, Italy.; Università Milano-Bicocca, Milan, Italy., De Jonge N; Amsterdam UMC, location VUmc, Amsterdam, Netherlands., Adžić-Vukičević T; COVID Hospital 'Batajnica', Belgrade, Serbia., Nunes-Rodrigues R; Portuguese Institute of Oncology, Lisbon, Portugal., Prezioso L; U.O. Ematologia e Centro Trapianti Midollo Osseo, Ospedale Maggiore, Parma, Italy., Navrátil M; University Hospital Ostrava, Ostrava, Czechia., Marchetti M; Hematology and BMT Unit, Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy., Cuccaro A; Hematology Unit, Center for Translational Medicine, Azienda USL Toscana NordOvest, Livorno, Italy., Calbacho M; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., Giordano A; Hematology Unit, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Rome, Italy.; Hematology Unit, Università Cattolica del Sacro Cuore, Rome, Italy., Cornely OA; Faculty of Medicine and University Hospital Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), University of Cologne, Cologne, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Clinical Trials Centre Cologne (ZKS Köln), Cologne, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany., Hernández-Rivas JÁ; Hematology Deparment, Hospital Universitario Infanta Leonor, Madrid, Spain>., Pagano L; Hematology Unit, Università Cattolica del Sacro Cuore, Rome, Italy.
Source: Frontiers in oncology [Front Oncol] 2022 Oct 03; Vol. 12, pp. 992137. Date of Electronic Publication: 2022 Oct 03 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2234-943X
DOI:10.3389/fonc.2022.992137